Table 3. Evaluation of biochemical examinations using one-way analysis of variance (ANOVA).
| Sampling time | Group | AST (µkat/L) | ALT (µkat/L) | ALP (µkat/L) | GMT (µkat/L) | LD (µkat/L) | Lactate (mmol/L) |
|---|---|---|---|---|---|---|---|
| Before intubation | V (n=6) | 0.520 (0.473; 0.625) | 0.900 (0.843; 0.985) | 3.383±0.356 | 0.645 (0.463; 0.750) | 10.215 (8.883; 11.910) | 1.560 (1.225; 1.845) |
| P (n=6) | 0.485 (0.453; 0.670) | 1.010 (0.933; 1.212) | 3.215±0.998 | 0.270 (0.235; 0.315) | 9.280 (8.393; 13.915) | 1.065 (0.845; 1.130) | |
| Before clamping | V (n=6) | 0.725 (0.652; 0.838) | 0.860 (0.815; 0.950) | 3.348±0.410 | 0.620 (0.468; 0.712) | 10.340 (9.420; 11.598) | 1.260 (1.150; 1.560) |
| P (n=6) | 0.735 (0.570; 1.033) | 1.040 (0.945; 1.260) | 3.257±1.069 | 0.270 (0.235; 0.305) | 9.705 (8.793; 12.990) | 1.335 (1.028; 1.652) | |
| After ischemia | V (n=6) | 2.550 (1.113; 4.053) | 0.935 (0.835; 1.073) | 3.860±0.511 | 0.625 (0.470; 0.745)* | 11.015 (9.797; 13.483) | 1.890 (1.103; 2.013) |
| P (n=6) | 1.220 (0.717; 1.495) | 1.030 (0.948; 1.223) | 3.608±1.085 | 0.270 (0.220; 0.310)* | 9.825 (9.067; 12.063) | 2.345 (1.748; 2.750) | |
| After reperfusion | V (n=6) | 2.855 (0.982; 6.887) | 0.930 (0.883; 1.053) | 4.043±0.910 | 0.555 (0.395; 0.675) | 12.325 (10.422; 14.813) | 1.995 (1.663; 2.802) |
| P (n=6) | 1.675 (1.148; 2.650) | 1.070 (0.945; 1.223) | 3.497±0.992 | 0.260 (0.232; 0.308) | 10.205 (9.152; 12.435) | 1.795 (1.440; 2.020) |
Values are expressed as medians (quartile Q0.25; quartile Q0.75) or as mean ± standard deviation, statistically significant differences between groups at a significance level of P<0.050 are marked with *. V, intervention group; P, control group; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; GMT, gamma-glutamyl-transferase; LD, lactate dehydrogenase.